Navigation Links
Compound shows promise against intractable heart failure
Date:2/11/2010

A chemical compound found normally in the blood has shown promise in treating and preventing an intractable form of heart failure in a mouse model of the disease, report researchers at the University of Illinois at Chicago College of Medicine.

The study is published in the February issue of Circulation.

More than five and half million Americans have heart failure, according to the American Heart Association, and 670,000 new cases are diagnosed each year.

In heart failure the heart is unable to pump effectively and cannot meet the body's need for blood and oxygen. It is really two diseases, each with about half of all patients, says Dr. Samuel Dudley, professor of medicine and physiology at UIC and chair of the section of cardiology. Systolic heart failure occurs when the heart can no longer contract effectively. In diastolic heart failure, the heart is unable to relax after contraction.

"Although we have a number of treatments for systolic heart failure, there are no approved treatments at all for diastolic heart failure, a deadly disease with a 60 percent mortality rate five years after diagnosis," said Dudley.

Hypertension is the cause in the overwhelming majority of diastolic heart failure cases.

"We know from previous studies that nitric oxide (NO) is necessary for blood vessel relaxation," said Dudley, "and that hypertension can lead to a decrease of NO in blood vessels."

Dudley and his colleagues knew that -- in blood vessels -- the problem was depletion of a chemical called tetrahydrobiopterin, or BH4, which is needed for the tissues to make NO.

"We decided to try thinking of the heart as a huge blood vessel that might also be unable to make the NO it needed due to long-term hypertension, and see if adding BH4 could make a difference," said Dudley.

They found that by giving mice BH4 they were not only able to prevent diastolic heart failure from developing, but to
'/>"/>

Contact: Jeanne Galatzer-Levy
jgala@uic.edu
312-996-1583
University of Illinois at Chicago
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Coloring Compound in Fruits, Veggies May Cut Colon Cancer Risk
2. Sugary Sodas High in Diabetes-Linked Compound
3. Red wine compound shown to prevent prostate cancer
4. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
5. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
6. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
7. Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma
8. Primus Innovations and Health Robotics Launch Strategic Partnership to Accelerate Transformation in Chemotherapy Compounding
9. Cannabis Compound May Stop Metastatic Breast Cancer
10. Prostate Cancer Treatments Often Compound Existing Health Problems
11. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , ... July 29, 2015 , ... Andrzej Klos, M.D., ... Klos, a board-certified pediatrician for nearly 38 years, is motivated each and every day ... commitment to his profession shine alongside his many awards and accolades, which include multiple ...
(Date:7/29/2015)... ... July 29, 2015 , ... Gender minority people ... 2012, Massachusetts law has provided legal protections against discrimination on the basis of ... not protect against discrimination based on gender identity in places open to the ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... paper, Our Best Shot: Expanding Prevention through Vaccination in Older Adults, that provides ... offers recommendations on how industry, government, and health care experts can improve patient ...
(Date:7/29/2015)... ... July 29, 2015 , ... According to the The Media Post ... are exposed to advertisements, for medicinal use are more likely to abuse the substance. ... use of marijuana is considered beneficial are more apt to use the substance, as ...
(Date:7/29/2015)... ... July 29, 2015 , ... " Core Organizer ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... this app will help anyone get organized. , Wouldn’t it be great if everyone ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 2Health News:NJ Top Docs Presents, Dr. Andrzej Klos of Carepoint Health Pediatrics! 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:Vaccination Rates in Older Adults Fall Short of Targets 2Health News:Vaccination Rates in Older Adults Fall Short of Targets 3Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Get More Organized with the Core Organizer App 2
... , THURSDAY, Feb. 17 (HealthDay News) -- Each year in ... 2 arrive in emergency rooms with injuries suffered while in ... of these injuries involve cribs and are usually caused by ... researchers from Nationwide Children,s Hospital in Columbus, Ohio. "The ...
... Arthritis affected about 3.1 million Hispanics in the United States ... arthritis rates among Hispanic subgroups, according to a new federal ... low of 11.7 percent among Cuban Americans to a high ... of National Health Interview Survey data from 2002, 2003, 2006 ...
... exposure from cell phone use does not appear to ... significant amount, a study by University of Manchester scientists ... the UK Office of National Statistics to look at ... England between 1998 and 2007. The study, published ...
... age, not being able to dress yourself or walk up ... set in could help. But so could going out ... to research conducted at Rush University Medical Center, higher levels ... becoming disabled. The study has just been posted online ...
... University of Pennsylvania School of Medicine report the discovery ... first reliable blood test to predict ectopic pregnancies. Their ... the Journal of Proteome Research , currently available ... published recently in the journal Fertility and Sterility ...
... HealthDay Reporter , WEDNESDAY, Feb. 16 (HealthDay News) ... infants who develop an eye condition that may cause blindness: ... treating the condition than the existing therapy. Just 4 ... a recurrence of retinopathy of prematurity, a disease that harms ...
Cached Medicine News:Health News:Crib Injuries Land Thousands of Toddlers in ER Each Year 2Health News:Crib Injuries Land Thousands of Toddlers in ER Each Year 3Health News:3.1 Million Hispanic Americans Struggle With Arthritis 2Health News:Cell-phone use not related to increased brain cancer risk 2Health News:Higher levels of social activity decrease the risk of developing disability in old age 2Health News:Biomarker discovery may lead to reliable blood test for ectopic pregnancy 2Health News:Biomarker discovery may lead to reliable blood test for ectopic pregnancy 3Health News:New Eye Treatment May Save Preemies' Sight 2Health News:New Eye Treatment May Save Preemies' Sight 3
(Date:7/29/2015)...   KaloBios Pharmaceuticals, Inc . (Nasdaq: KBIO ... therapies to benefit patients with diseases of unmet medical ... the U.S. Food and Drug Administration (FDA) has cleared ... an anti-GM-CSF monoclonal antibody (mAb), in patients with chronic ... active. The acceptance of this IND allows ...
(Date:7/29/2015)... , July 29, 2015  Ortho-Clinical Diagnostics, Inc. ... assays under development. The assays address a range of ... injury and cardiac troponin I. The scientific posters will ... Chemistry Annual Meeting to be held July 26 - ... "Ortho Clinical Diagnostics is emerging stronger than ...
(Date:7/29/2015)... , July 27, 2015 Research ... addition of the "Global Neurostimulation Devices Market ... The analysts forecast the global neurostimulation devices market ... the period 2014-2019. The report, Global ... on an in-depth market analysis with inputs from ...
Breaking Medicine Technology:KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 2KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 3KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 4KaloBios Announces FDA Clearance of Investigational New Drug Application for KB003 in Patients with Chronic Myelomonocytic Leukemia 5Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 2Ortho-Clinical Diagnostics, Inc. Presents Data On Five Assays In Development At American Association For Clinical Chemistry Annual Meeting 3Global Neurostimulation Devices Market 2015-2019 2
... - Poster Presented at ASCO Annual Meeting ... CHICAGO, May 31 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. ... on oncology, today presented preliminary safety and,efficacy ... trial of picoplatin in,combination with docetaxel and ...
... 3 Study Presented at ASCO -, COLLEGEVILLE, ... Wyeth (NYSE: WYE ), today announced results,of ... patients with relapsed,and/or refractory mantle cell lymphoma (MCL), ... (mammalian target of rapamycin) inhibitor,TORISEL(R) (temsirolimus) experienced a ...
Cached Medicine Technology:Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 2Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 3Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 2New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 3New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 4New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 5New Data Show TORISEL Improves Progression-Free Survival for Patients With Relapsed/Refractory Mantle Cell Lymphoma 6
Drugs of Abuse (DoA) Array is used for in-vitro diagnostic tests for the qualitative determination of the parent molecule and metabolites of drugs in human urine....
For use with catalog #0540, 0887....
Enzyme Immunoassay of D-Dimer by ELISA Method, 96 tests....
Detection of Lupus Anticoagulants. Freeze-dried hexagonal phase phos-phatidylethanolamine; normal plasmawith heparin inhibitor; PTT-LS reagent of cephalin and particulate siliceous activator;all free...
Medicine Products: